Zeesan

company

About

Zeesan is a biomedical company that specializes in the development and production of molecular diagnostics kits.

  • 51 - 100

Details

Last Funding Type
Post-IPO Equity
Last Funding Money Raised
¥30.80M
Industries
Biotechnology,Health Diagnostics,Medical
Founded date
Jun 12, 2010
Number Of Employee
51 - 100
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
¥45.80M $10M
Zeesan has raised a total of ¥45.80M $10M in funding over 2 rounds. Their latest funding was raised on Jun 7, 2021 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 7, 2021 Post-IPO Equity $10M 3 Detail
Jul 28, 2015 Post-IPO Equity ¥30.80M 2 Detail
Feb 19, 2014 Series A ¥10M 1 Detail
Feb 16, 2012 Angel ¥5M 1 Detail

Investors

Number of Lead Investors
Number of Investors
6
Zeesan is funded by 6 investors. Qianhai Dingfeng Investment and Xuankai Touzi are the most recent investors.
Investor Name Lead Investor Funding Round
Qianhai Dingfeng Investment Post-IPO Equity
Xuankai Touzi Post-IPO Equity
Dirui Zichan Post-IPO Equity
Yinhua Caifu Post-IPO Equity
Dingfeng Asset Post-IPO Equity
HY Venture Series A